Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Randers ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.9% 1.2% 0.8% 0.7% 0.8% 0.9% 6.7% 6.7%   Credit score (0-100)   71 82 91 93 91 89 36 36   Credit rating   A A AA AA A A BBB BBB   Credit limit (kDKK)   0.6 79.9 642.6 499.8 561.2 713.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,439 10,889 11,517 11,783 13,742 15,497 0.0 0.0   EBITDA   1,412 1,749 3,104 1,942 2,288 3,148 0.0 0.0   EBIT   674 949 2,388 1,205 1,600 2,560 0.0 0.0   Pre-tax profit (PTP)   500.9 747.6 2,414.3 1,124.0 1,531.6 2,549.6 0.0 0.0   Net earnings   386.8 578.9 1,881.1 829.2 1,194.0 1,986.8 0.0 0.0   Pre-tax profit without non-rec. items   501 748 2,414 1,124 1,532 2,550 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   976 676 615 352 139 1,296 0.0 0.0   Shareholders equity total   875 1,454 3,336 2,265 3,059 4,296 2,747 2,747   Interest-bearing liabilities   4,157 3,798 2,407 1,722 36.4 0.0 0.0 0.0   Balance sheet total (assets)   8,190 6,623 9,115 5,839 5,283 6,601 2,747 2,747   Net Debt   3,683 3,764 129 1,022 -928 -1,283 -924 -924     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,439 10,889 11,517 11,783 13,742 15,497 0.0 0.0   Gross profit growth   6.3% 15.4% 5.8% 2.3% 16.6% 12.8% -100.0% 0.0%   Employees   0 25 26 26 29 29 0 0   Employee growth %   0.0% 0.0% 4.0% 0.0% 11.5% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,190 6,623 9,115 5,839 5,283 6,601 2,747 2,747   Balance sheet change%   105.0% -19.1% 37.6% -35.9% -9.5% 24.9% -58.4% 0.0%   Added value   1,411.5 1,749.2 3,103.8 1,941.9 2,337.7 3,147.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,078 -1,574 -1,251 -1,475 -1,375 141 -1,296 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.1% 8.7% 20.7% 10.2% 11.6% 16.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.9% 12.8% 32.4% 16.3% 28.8% 43.2% 0.0% 0.0%   ROI %   18.8% 17.6% 42.6% 22.0% 40.1% 65.5% 0.0% 0.0%   ROE %   27.1% 49.7% 78.5% 29.6% 44.9% 54.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   10.7% 22.0% 36.6% 38.8% 57.9% 65.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   261.0% 215.2% 4.2% 52.6% -40.6% -40.8% 0.0% 0.0%   Gearing %   474.9% 261.2% 72.1% 76.0% 1.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.7% 5.1% 4.4% 4.6% 7.8% 93.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.1 1.6 1.6 1.6 1.4 0.0 0.0   Current Ratio   0.8 1.2 1.6 1.7 1.7 1.4 0.0 0.0   Cash and cash equivalent   473.8 34.7 2,277.3 700.0 964.2 1,283.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -715.0 374.0 1,936.2 964.0 1,039.8 875.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 70 119 75 81 109 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 70 119 75 79 109 0 0   EBIT / employee   0 38 92 46 55 88 0 0   Net earnings / employee   0 23 72 32 41 69 0 0